NONOF - Eli Lilly reportedly hit by fake versions of next-gen weight loss drug
2023-10-20 07:47:18 ET
More on Eli Lilly
- Eli Lilly: The GLP-1 Opportunity, While Increasingly Recognized, Is Vastly Underestimated
- Eli Lilly: Do Not Chase This Stock Over The Cliff
- Eli Lilly: Big Cancer Bet With Point Biopharma Global Purchase
- Eli Lilly files complaint over alleged fake versions of diabetes drug Mounjaro
- Eli Lilly said to have hired CDMO CordenPharma for Mounjaro API
For further details see:
Eli Lilly reportedly hit by fake versions of next-gen weight loss drug